CLINICAL TRIALS PROFILE FOR TOPICORT LP
✉ Email this page to a colleague
All Clinical Trials for TOPICORT LP
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02340169 ↗ | Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis | Completed | Taro Pharmaceuticals USA | Phase 4 | 2015-01-23 | The objective of this study is to evaluate the potential of Topicort® (desoximetasone) Topical Spray, 0.25% to suppress hypothalmic pituitary adrenal axis function. The secondary objectives are to evaluate the efficacy parameters, pharmacokinetics and adverse event profile. |
NCT02983981 ↗ | Topical Psoriasis Study for Patients Receiving Biologic Therapy | Completed | Taro Pharmaceuticals USA | Phase 4 | 2016-03-01 | A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who are receiving biologic therapy for at least 24 weeks |
NCT02983981 ↗ | Topical Psoriasis Study for Patients Receiving Biologic Therapy | Completed | Psoriasis Treatment Center of Central New Jersey | Phase 4 | 2016-03-01 | A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who are receiving biologic therapy for at least 24 weeks |
NCT02985736 ↗ | Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray | Completed | Taro Pharmaceuticals USA | Phase 4 | 2016-09-01 | A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis |
NCT02985736 ↗ | Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray | Completed | Psoriasis Treatment Center of Central New Jersey | Phase 4 | 2016-09-01 | A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TOPICORT LP
Condition Name
Clinical Trial Locations for TOPICORT LP
Trials by Country
Clinical Trial Progress for TOPICORT LP
Clinical Trial Phase
Clinical Trial Sponsors for TOPICORT LP
Sponsor Name